Study of Adalimumab in Patients With Axial Spondyloarthritis

NCT00939003 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Axial Spondyloarthritis

Interventions

BIOLOGICAL: Adalimumab
BIOLOGICAL: Placebo
BIOLOGICAL: Open-label Adalimumab

Sponsor

AbbVie (prior sponsor, Abbott)